https://www.selleckchem.com/pr....oducts/rgd-peptide-g
Approximately half of surveyed PWID who use opioids still reported no treatment with either medication, highlighting remaining treatment gaps. Among PWID who use opioids in the Seattle area, methadone use increased 38%, and buprenorphine use more than quadrupled from 2015 to 2018. Approximately half of surveyed PWID who use opioids still reported no treatment with either medication, highlighting remaining treatment gaps. Closures and reductions in capacity of select health and social services in response to the COVID-19 pand
Like
Comment
Share
